Pharma, food driving batch control market
Batch control systems are becoming increasingly used by the pharmaceutical and food industries as they increasingly rely on automation to improve productivity and product quality.
Archives for July 3, 2005
Sigma launches FluoroProfile
Sigma Aldrich has launched a new kit, which incorporates a novel approach for the fluorescent quantification of proteins offering numerous advantages over existing kits that include reversible covalent binding, large dynamic range, improved...
Topical drug delivery gel patented by Foamix
Israeli drug delivery firm Foamix has been awarded a US patent for its OilGel technology, a semisolid matrix which turns into a liquid when rubbed onto the skin and can be used to deliver a broad range of therapeutic compounds.
Bayer publishes clinical trial data
Bayer Healthcare has announced that it will publish information about its ongoing clinical trials, reinforcing the intention of the pharmaceutical companies within the industry to provide an arena in which they can publish information on their...
Scientists show microRNA development role
US scientists have shown that microRNA (miRNA) plays an essential role in the development of the fruit fly. The discovery means that miRNA could emerge as a new target for interventions aimed at treating disease, or as a therapeutic in its own right.
Topigen introduces FANA technology for drug R&D
Topigen Pharmaceuticals has launched a new 3rd generation chemistry technology, which has been designed for improving oligonucleotide-based therapeutics that has the potential for broad gene-targeting drug applications.
Able unable to meet investors
The manufacturing compliance problems affecting US generic drug manufacturer Able Laboratories, which have prompted a huge recall of its entire product range, show little signs of being resolved, reports Phil Taylor.
Balchem raises pharma profile with Loders acquisition
Balchem has acquired the encapsulation and agglomeration business of IOI Group - part of Loders Croklaan USA - in a move that extends its activities in the food and pharmaceutical ingredient sectors.